Form D · Biotechnology
Agentix Corp.
Dana Point, CA · CIK 0001603345
Offering snapshot reported Feb 11, 2021 · SEC filing
- Reported sold
- $688K Offering amount: $4M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jun 22, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 11, 2021 | Initial | $688,333 | No comparison | 10 | SEC filing |
| Apr 2, 2015 | Initial | $120,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-389239
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Agentix Corp. | None |
Source: Form D, filed Feb 11, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Drust | Director |
| Salman Hoda | Executive |
| Rehan Huda | Director |
| Eric Krogius | Director |
| Rudy Mazzocchi | Director, Executive |
| Scott Stevens | Director |
| Scott Thomas | Director, Executive |
| Michael Winterhalter | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
32932 Pacific Coast Highway, #14 254
Dana Point, CA, 92629
Dana Point, CA, 92629